-
A
Experimental design for WWL229 treatment in a renal I/R‐induced model. All the results shown in this figure were obtained under I/R 3D injury.
-
B, C
Representative H&E images (B) with pathological scores (C) of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups. Scale bar = 100 μm.
-
D
mRNA levels of Kim1 and Ngal of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups.
-
E
Representative Oil Red O staining with quantification of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups. Scale bar = 100 μm.
-
F
mRNA levels of fatty acid oxidation related genes of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups.
-
G
Representative Cpt1a immunostaining with quantitative analysis in the kidneys of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups. Scale bar = 50 μm. IOD, integral optical density.
-
H–J
mRNA level of Ces1 of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups (H); representative immunoblots with quantitative results of Ces1 of WT + Veh (n = 3), WT + WWL (n = 3), Ehmt2
Ksp
+ Veh (n = 3) and Ehmt2
Ksp
+ WWL (n = 3) groups (I); and carboxylesterase enzymatic activity (J) of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups.
-
K, L
Representative immunostaining for CD3 and F4/80 (K) and quantitative results (L) of WT + Veh (n = 5), WT + WWL (n = 4), Ehmt2
Ksp
+ Veh (n = 4) and Ehmt2
Ksp
+ WWL (n = 4) groups. Scale bar = 50 μm.
-
M
Representative immunoblots (left) with quantitative results (right) of p‐Mlkl for WT + Veh (n = 3), WT + WWL (n = 3), Ehmt2
Ksp
+ Veh (n = 3) and Ehmt2
Ksp
+ WWL (n = 3) groups.